Eurofins-Cerep SA (EPA:ALECR)

Market Cap	103.91M
Revenue (ttm)	44.07M
Net Income (ttm)	7.64M
Shares Out	5.04K
EPS (ttm)	n/a
PE Ratio	13.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3
Average Volume	0
Open	20,600
Previous Close	20,600
Day's Range	20,600 - 20,600
52-Week Range	18,000 - 23,800
Beta	0.64
RSI	75.33
Earnings Date	Apr 29, 2025

About Eurofins-Cerep

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company’s research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Employees: 228
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALECR

Financial Performance

In 2023, Eurofins-Cerep's revenue was 44.07 million, a decrease of -7.51% compared to the previous year's 47.65 million. Earnings were 7.64 million, a decrease of -33.72%.